Multi-organ point-of-care ultrasound for COVID-19 (PoCUS4COVID): international expert consensus
Arif Hussain,Gabriele Via,Lawrence Melniker,Alberto Goffi,Guido Tavazzi,Luca Neri,Tomas Villen,Richard Hoppmann,Francesco Mojoli,Vicki Noble,Laurent Zieleskiewicz,Pablo Blanco,Irene W Y Ma,Mahathar Abd Wahab,Abdulmohsen Alsaawi,Majid Al Salamah,Martin Balik,Diego Barca,Karim Bendjelid,Belaid Bouhemad,Pablo Bravo-Figueroa,Raoul Breitkreutz,Juan Calderon,Jim Connolly,Roberto Copetti,Francesco Corradi,Anthony J Dean,André Denault,Deepak Govil,Carmela Graci,Young-Rock Ha,Laura Hurtado,Toru Kameda,Michael Lanspa,Christian B Laursen,Francis Lee,Rachel Liu,Massimiliano Meineri,Miguel Montorfano,Peiman Nazerian,Bret P Nelson,Aleksandar N Neskovic,Ramon Nogue,Adi Osman,José Pazeli,Elmo Pereira-Junior,Tomislav Petrovic,Emanuele Pivetta,Jan Poelaert,Susanna Price,Gregor Prosen,Shalim Rodriguez,Philippe Rola,Colin Royse,Yale Tung Chen,Mike Wells,Adrian Wong,Wang Xiaoting,Wang Zhen,Yaseen Arabi
DOI: https://doi.org/10.1186/s13054-020-03369-5
2020-12-24
Abstract:COVID-19 has caused great devastation in the past year. Multi-organ point-of-care ultrasound (PoCUS) including lung ultrasound (LUS) and focused cardiac ultrasound (FoCUS) as a clinical adjunct has played a significant role in triaging, diagnosis and medical management of COVID-19 patients. The expert panel from 27 countries and 6 continents with considerable experience of direct application of PoCUS on COVID-19 patients presents evidence-based consensus using GRADE methodology for the quality of evidence and an expedited, modified-Delphi process for the strength of expert consensus. The use of ultrasound is suggested in many clinical situations related to respiratory, cardiovascular and thromboembolic aspects of COVID-19, comparing well with other imaging modalities. The limitations due to insufficient data are highlighted as opportunities for future research.